BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 19864026)

  • 1. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D; Donin N; Fishelson Z
    Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.
    Fogarty MP; Downer EJ; Campbell V
    Biochem J; 2003 May; 371(Pt 3):789-98. PubMed ID: 12534344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
    Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation.
    Yao K; Cho YY; Bergen HR; Madden BJ; Choi BY; Ma WY; Bode AM; Dong Z
    Cancer Res; 2007 Sep; 67(18):8725-35. PubMed ID: 17875713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cells.
    David S; Hila S; Fosbrink M; Rus H; Koski CL
    J Peripher Nerv Syst; 2006 Mar; 11(1):77-87. PubMed ID: 16519786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
    Oleinik NV; Krupenko NI; Krupenko SA
    Oncogene; 2007 Nov; 26(51):7222-30. PubMed ID: 17525747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.
    Ma FY; Flanc RS; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
    J Am Soc Nephrol; 2007 Feb; 18(2):472-84. PubMed ID: 17202416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A JNK1/AP-1-dependent, COX-2 induction is implicated in 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation through regulating cell cycle progression.
    Zhang D; Li J; Song L; Ouyang W; Gao J; Huang C
    Mol Cancer Res; 2008 Jan; 6(1):165-74. PubMed ID: 18234971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAPKgamma/JNK1 and SAPKalpha/JNK2 mRNA transcripts are expressed in early gestation human placenta and mouse eggs, preimplantation embryos, and trophoblast stem cells.
    Zhong W; Sun T; Wang QT; Wang Y; Xie Y; Johnson A; Leach R; Puscheck EE; Rappolee DA
    Fertil Steril; 2004 Oct; 82 Suppl 3():1140-8. PubMed ID: 15474087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
    Katagiri C; Negishi K; Hibino T
    J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of apoptosis signal-regulating kinase 1 in complement-mediated glomerular epithelial cell injury.
    Ren G; Huynh C; Bijian K; Cybulsky AV
    Mol Immunol; 2008 Apr; 45(8):2236-46. PubMed ID: 18178252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
    Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression profiles of Jnk1- and Jnk2-deficient murine fibroblast cells.
    Chen N; She QB; Bode AM; Dong Z
    Cancer Res; 2002 Mar; 62(5):1300-4. PubMed ID: 11888895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
    Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
    Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
    Yeap YY; Ng IH; Badrian B; Nguyen TV; Yip YY; Dhillon AS; Mutsaers SE; Silke J; Bogoyevitch MA; Ng DC
    Biochem J; 2010 Sep; 430(2):345-54. PubMed ID: 20594188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.
    Wang Y; Luo W; Reiser G
    Biochem J; 2007 Jan; 401(1):65-78. PubMed ID: 16942465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
    Zhou JY; Liu Y; Wu GS
    Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
    Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
    Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun N-terminal kinase regulates CTP:phosphocholine cytidylyltransferase.
    Ryan AJ; Andrews M; Zhou J; Mallampalli RK
    Arch Biochem Biophys; 2006 Mar; 447(1):23-33. PubMed ID: 16466687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.